BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...D (CLEC2D) antibodies inhibited CD161-CLEC2D interaction leading to NK cell mediated cytotoxicity in cell lines Zumutor Biologics Inc....
Items per page:
1 - 1 of 1
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...D (CLEC2D) antibodies inhibited CD161-CLEC2D interaction leading to NK cell mediated cytotoxicity in cell lines Zumutor Biologics Inc....
Items per page:
1 - 1 of 1